Piriformis Syndrome Market Overview:
The Global Piriformis Syndrome Market expected to drive the market by major factors such as growing occurrence of Piriformis Syndrome, increasing screening for neuromuscular conditions, growing success of drug treatment for the syndrome, and the growing geriatric population are expected to drive the growth of Additionally, according to the data published by the National Center for Biotechnology Information (NCBI), in 2015.
However, the complications of the piriformis surgery and lack of awareness about the syndrome in developing countries may hamper the growth of the market during the assessment period. Furthermore, challenges in the diagnosis of the piriformis syndrome may hamper the growth of the market.
Piriformis Syndrome Key Players Overview:
Bayer AG, Novartis AG, AstraZeneca, Endo Pharmaceuticals, Teva Pharmaceuticals, Omron Healthcare, Sanofi S.A., DePuy Synthes Companies, Miracle Stretch, LLC, Flex Pharma, Inc., Nidd valley medical, SEIRIN Corporation and others.
Get Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/6249 .
Segmentation:
The Global Piriformis Syndrome Market is segmented on the basis of cause, diagnostic test, treatment, distribution channel, and end-user. On the basis of cause, the market is classified as trauma, spasms, overuse injury, and others.
The piriformis syndrome market on the basis of diagnostic tests is segmented as Magnetic Resonance Imaging (MRI), X-ray, Computed Tomography (CT), neurophysiologic testing, Electromyography (EMG), Beatty Test, FAIR (Flexion, adduction, and Internal Rotation) test, and others.
On the basis of treatment, the market is segmented into medication, physical therapy, acupuncture, prolotherapy, Osteopathic Manipulative Treatment (OMT), surgery, and others. The medication is further segmented into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), piriformis muscle injection, and others. NSAIDs are further segmented into naproxen, ibuprofen, and others. Further, the piriformis muscle injection is segmented into Botox injection, steroid injections, and others.
The global piriformis syndrome market, by distribution channel, is segmented into E-commerce, retail pharmacies and others.
On the basis of end-user, the global piriformis syndrome market is segmented as hospitals and clinics, diagnostic centers, and others.
Geographically, the global piriformis syndrome market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The American piriformis syndrome market is further segmented into North America and South America. North America is further classified as the US and Canada.
Get Discount @ https://www.marketresearchfuture.com/check-discount/6249 .
The European piriformis syndrome market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The piriformis syndrome market in Asia-Pacific is segmented into Japan, China, India, the Republic of Korea, Australia, and the Rest of Asia-Pacific.
The Middle Eastern and African piriformis syndrome market is segmented into the Middle East and Africa.
Piriformis Syndrome Market Regional Analysis:
The Global Piriformis Syndrome Market consists of four regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The North American region holds the major share of the global piriformis syndrome market, owing to the existing well-established healthcare system, increasing secondary lifestyle, and increasing geriatric population.
Additionally, a large number of orthopedic procedures due to greater healthcare penetration in the US and Canada contributes to the growth of the market. Europe is anticipated to hold the second largest position in the global piriformis market owing to the growing government support for research and development activities. Additionally, Asia-Pacific the piriformis market in Asia-Pacific consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the rest of Asia-Pacific.
The Asia-Pacific region is anticipated to be the fastest growing region in the market owing to the huge population base and rising healthcare expenditure. Furthermore, the Middle East and Africa holds the lowest share of the global market owing to the lack of awareness about the syndrome and poor economic conditions, especially in the African region.
Ask to Expertise @ https://www.marketresearchfuture.com/enquiry/6249 .
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Your information will never be shared with any third party.